West Nile virus-associated meningoencephalitis in two chronically immunosuppressed renal transplant recipients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 14510707)

Published in Am J Transplant on October 01, 2003

Authors

Karen L Hardinger1, Brent Miller, Gregory A Storch, Niraj M Desai, Daniel C Brennan

Author Affiliations

1: Pharmacy, Barnes-Jewish Hospital, Washington University, St Louis, MO, USA. klh2562@bjc.org

Articles by these authors

International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43

In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73

Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01

Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75

Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation (2008) 3.43

Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep (2006) 3.32

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation (2009) 2.33

Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation (2014) 2.26

Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis (2009) 2.24

Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22

Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes (2004) 2.22

Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19

Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17

Detection of newly described astrovirus MLB1 in stool samples from children. Emerg Infect Dis (2009) 2.02

MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol (2007) 1.98

Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96

Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93

Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial. Infect Control Hosp Epidemiol (2011) 1.92

Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics (2008) 1.85

Center-level factors and racial disparities in living donor kidney transplantation. Am J Kidney Dis (2012) 1.82

Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation (2012) 1.78

Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol (2003) 1.77

Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75

Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology (2012) 1.75

contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis (2009) 1.74

Living donation decision making: recipients' concerns and educational needs. Prog Transplant (2006) 1.73

Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant (2005) 1.73

Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67

Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin Infect Dis (2007) 1.63

Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation (2014) 1.62

Atypical avian influenza (H5N1). Emerg Infect Dis (2004) 1.60

Operative parameters that predict the outcomes of hepatic transplantation. J Am Coll Surg (2003) 1.58

Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes. Transplantation (2010) 1.57

Sequence analysis of the human virome in febrile and afebrile children. PLoS One (2012) 1.56

Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation (2004) 1.51

Genome sequence of enterovirus D68 from St. Louis, Missouri, USA. Emerg Infect Dis (2015) 1.49

Clinical and epidemiologic characterization of WU polyomavirus infection, St. Louis, Missouri. Emerg Infect Dis (2007) 1.48

Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45

Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J (2012) 1.44

Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol (2002) 1.38

Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Infect (2009) 1.37

BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol (2007) 1.36

Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis (2007) 1.36

Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33

Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis (2005) 1.31

Frailty and delayed graft function in kidney transplant recipients. Arch Surg (2012) 1.30

BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol (2008) 1.25

Detection of viruses in young children with fever without an apparent source. Pediatrics (2012) 1.23

Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22

The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation (2003) 1.22

Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21

Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol (2010) 1.17

Emerging view of the human virome. Transl Res (2012) 1.17

Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure. Am J Kidney Dis (2009) 1.15

Astrovirus MLB2 viremia in febrile child. Emerg Infect Dis (2011) 1.14

Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation (2006) 1.13

Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol (2006) 1.13

Invasive honeysuckle eradication reduces tick-borne disease risk by altering host dynamics. Proc Natl Acad Sci U S A (2010) 1.12

Gene expression profiles in febrile children with defined viral and bacterial infection. Proc Natl Acad Sci U S A (2013) 1.11

Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol (2005) 1.11

Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg (2006) 1.11

Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient. Arch Ophthalmol (2008) 1.09

De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis (2005) 1.09

Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation (2004) 1.07

Blood meal analysis to identify reservoir hosts for Amblyomma americanum ticks. Emerg Infect Dis (2010) 1.07

Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation (2007) 1.06

Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness. Thorax (2010) 1.05

Inferring expertise in knowledge and prediction ranking tasks. Top Cogn Sci (2012) 1.05

Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol (2014) 1.05

Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine. Pediatrics (2006) 1.05

Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation (2014) 1.04

Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness. J Infect Dis (2005) 1.04

Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04

The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation (2003) 1.03

Correlation of cerebrospinal fluid (CSF) cell counts and elevated CSF protein levels with enterovirus reverse transcription-PCR results in pediatric and adult patients. J Clin Microbiol (2004) 1.03

Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest (2007) 1.03

Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med (2008) 1.03

The natural history of contemporary Staphylococcus aureus nasal colonization in community children. Pediatr Infect Dis J (2011) 1.03

Inhibitory interactions between BK and JC virus among kidney transplant recipients. J Am Soc Nephrol (2011) 1.03

Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol (2008) 1.02

A significant role for histocompatibility in human islet transplantation. Transplantation (2006) 1.02

Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation (2002) 1.02

The role of tacrolimus in renal transplantation. Expert Opin Pharmacother (2008) 1.02

Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients. Transplantation (2004) 1.02

Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients. Transplantation (2012) 1.01

Comparison of the Eragen Multi-Code Respiratory Virus Panel with conventional viral testing and real-time multiplex PCR assays for detection of respiratory viruses. J Clin Microbiol (2010) 1.01

The life-years saved by a deceased organ donor. Am J Transplant (2005) 1.00

Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation (2002) 0.99